Ledger.Open graph →
SEC Form D · filed October 7, 2015

Elcelyx Therapeutics, Inc

Offering
$40.2M
Sold
$20.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Ginger E. Graham · San Diego, CADirectorMark R. Fineman · San Diego, CAExecJim E. Glasheen · San Diego, CADirectorMartin R. Brown · San Diego, CAExecAlain D. Baron · San Diego, CAExec · DirectorRichard J. Barry · San Diego, CADirectorRalph E. Christofferson · San Diego, CADirectorLiang R. Tsui · San Diego, CADirectorArthur Budman · SAN DIEGO, CADirectorGeoffrey M. Henry · Luxembourg City, N7ExecJoseph J. Walsh · Boca Raton, FLExecNicholas Yates · SAN DIEGO, CADirectorAlex Kennedy · SAN DIEGO, CAExecSteven Finley · SAN DIEGO, CADirectorPeter D. Beetham · San Diego, CADirectorJavier R. Pages · Luxembourg City, LuxembourgDirectorRichard J. Schwab · Iowa City, IAExec · DirectorGary J. Ortale · Iowa City, IADirectorTracy S. Mccormick · Iowa City, IAExec · DirectorLiang R. Tsui · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗